Evidence map›Paper›PMID 27897348›Full record

ArticleChemistry (Weinheim an der Bergstrasse, Germany)2017

Enzymatic Activity and Thermodynamic Stability of Biliverdin IXβ Reductase Are Maintained by an Active Site Serine.

Wen-Ting Chu, Natasha M Nesbitt, Dmitri V Gnatenko, Zongdong Li, Beibei Zhang, Markus A Seeliger, Seamus Browne, Timothy J Mantle, Wadie F Bahou, Jin Wang

Abstract read
In one paragraph

Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Modulating Enzyme FunctionFrontiers in molecular biosciences · 2021
    Article
  10. Review
  11. Article
  12. The Journal of biological chemistry · 2018
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Wen-Ting ChuState Key Laboratory of Electroanalytical Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin, 130022, P. R. China.
Natasha M NesbittDepartment of Medicine, Stony Brook University, Stony Brook, NY, 11794, USA.
Dmitri V GnatenkoDepartment of Medicine, Stony Brook University, Stony Brook, NY, 11794, USA.
Zongdong LiDepartment of Medicine, Stony Brook University, Stony Brook, NY, 11794, USA.
Beibei ZhangDepartment of Biochemistry and Cell Biology, Stony Brook University, Stony Brook, NY, 11794, USA.
Markus A SeeligerDepartment of Pharmacological Sciences, Stony Brook University, Stony Brook, NY, 11794, USA.
Seamus BrowneDepartment of Biochemistry, Trinity College, Dublin 2, Ireland.
Timothy J MantleDepartment of Biochemistry, Trinity College, Dublin 2, Ireland.
Wadie F BahouDepartment of Medicine, Stony Brook University, Stony Brook, NY, 11794, USA.
Jin WangState Key Laboratory of Electroanalytical Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin, 130022, P. R. China.

Funding

Dynamics of Ligand Binding and Protein Kinase Regulation_RenewalR35GM119437 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI Markus A Seeliger · 2016 to 2026
$6.5M
Platelet Systems Biology in Health and DiseaseR01HL119096 · NHLBI · STATE UNIVERSITY NEW YORK STONY BROOK · PI BAHOU, WADIE F · 2015 to 2019
$3.5M
Genetic dissection of the platelet thrombohemorrhagic phenotypeR01HL091939 · NHLBI · STATE UNIVERSITY NEW YORK STONY BROOK · PI BAHOU, WADIE F · 2009 to 2012
$1.6M
Development of a biliverdin IX Beta reductase redox inhibitor for enhanced platelet productionR43HL129545 · NHLBI · BLOOD CELL TECHNOLOGIES, LLC · PI NESBITT, NATASHA M. · 2015 to 2015
$221k
NHLBI NIH HHS R01 HL091939NHLBI NIH HHS R01 HL119096NHLBI NIH HHS R43 HL129545NIGMS NIH HHS R35 GM119437
6 · The paper itself

Abstract

Biliverdin reductase IXβ (BLVRB) is a crucial enzyme in heme metabolism. Recent studies in humans have identified a loss-of-function mutation (Ser111Leu) that unmasks a fundamentally important role in hematopoiesis. We have undertaken experimental and thermodynamic modeling studies to provide further insight into the role of the cofactor in substrate accessibility and protein folding properties regulating BLVRB catalytic mechanisms. Site-directed mutagenesis with molecular dynamic (MD) simulations establish the critical role of NAD(P)H-dependent conformational changes on substrate accessibility by forming the "hydrophobic pocket", along with identification of a single key residue (Arg35) modulating NADPH/NADH selectivity. Loop80 and Loop120 block the hydrophobic substrate binding pocket in apo BLVRB (open), whereas movement of these structures after cofactor binding results in the "closed" (catalytically active) conformation. Both enzymatic activity and thermodynamic stability are affected by mutation(s) involving Ser111, which is located in the core of the BLVRB active site. This work 1) elucidates the crucial role of Ser111 in enzymatic catalysis and thermodynamic stability by active site hydrogen bond network; 2) defines a dynamic model for apo BLVRB extending beyond the crystal structure of the binary BLVRB/NADP

Indexed as

AnimalsBinding SitesCatalytic DomainHydrogen BondingKineticsMolecular Dynamics SimulationMutagenesis, Site-DirectedNADOxidoreductases Acting on CH-CH Group DonorsProtein StabilitySerineSubstrate SpecificityThermodynamicsbiliverdin reductaseNADOxidoreductases Acting on CH-CH Group DonorsSerinecofactorsconformation analysisenzyme catalysismolecular dynamicsmolecular modeling

Identifiers

PMID27897348
PMCPMC5293602

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.